Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Ho Joong Choi

Clin Mol Hepatol. 2022;28(1):117-119. Published online December 7, 2021

DOI: https://doi.org/10.3350/cmh.2021.0381

View: 4935 Download: 87 Web of Science: 7 Crossref: 9

Young Eun Chon, Soung Won Jeong, Dae Won Jun

Clin Mol Hepatol. 2021;27(3):512-514. Published online June 21, 2021

DOI: https://doi.org/10.3350/cmh.2021.0171

View: 5707 Download: 171 Web of Science: 24 Crossref: 24

Ja Yoon Choi, Jeong-Mi Lee, Yun Won Jo, Hyun Ju Min, Hyun Jin Kim, Woon Tae Jung, Ok Jae Lee, Haesun Yun, Yeong-Sil Yoon

Clin Mol Hepatol. 2013;19(3):309-314. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.309

View: 7897 Download: 60 Crossref: 33

1 |

Viewed By 5168	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5027	MAFLD: How is it different from NAFLD?
Viewed By 4972	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3646	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3603	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search